These observations were further corroborated by in silico analyses of TCGA data [41] obtained using cBioPortal [42], which demonstrated high-level CpG methylation of the CD38 locus, comparable to other known frequently methylated genes in prostate cancer such as GSTP1 and PTGS2 (Additional file 2). The gene discussed is CD38; the disease is prostate carcinoma.